Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Neuroendocrine Tumors"" wg kryterium: Temat


Tytuł :
Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer.
Autorzy :
Abiodun-Ojo OA; From the Departments of Radiology and Imaging Sciences.
Akintayo AA; From the Departments of Radiology and Imaging Sciences.
Harik LR; Pathology and Laboratory Medicine, Emory University School of Medicine.
Bilen M; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA.
Halkar RK; From the Departments of Radiology and Imaging Sciences.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 May 01; Vol. 46 (5), pp. e282-e285.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Carboxylic Acids/*metabolism
Cyclobutanes/*metabolism
Neuroendocrine Tumors/*metabolism
Neuroendocrine Tumors/*secondary
Prostatic Neoplasms, Castration-Resistant/*pathology
Aged ; Biological Transport ; Humans ; Male ; Neuroendocrine Tumors/diagnostic imaging ; Neuroendocrine Tumors/pathology
Czasopismo naukowe
Tytuł :
Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors.
Autorzy :
Oziel-Taieb S; Department of Medical Oncology, ENETS Center of Excellence, IPC NET Center, Institut Paoli-Calmettes, Marseille, France; .
Zemmour C; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Paoli-Calmettes, Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France.
Raoul JL; Department of Digestive Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
Mineur L; Gastro Intestinal and Liver Cancer Unit, Sainte-Catherine Institute, Avignon, France.
Poizat F; Department of Biopathology, ENETS Center of Excellence, IPC NET Center, Institut Paoli-Calmettes, Marseille, France.
Charrier N; Department of Nuclear Medicine, ENETS Center of Excellence, IPC NET Center, Institut Paoli-Calmettes, Marseille, France.
Piana G; Department of Radiology, ENETS Center of Excellence, IPC NET Center, Institut Paoli-Calmettes, Marseille, France.
Cavaglione G; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
Niccoli P; Department of Medical Oncology, ENETS Center of Excellence, IPC NET Center, Institut Paoli-Calmettes, Marseille, France.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Apr; Vol. 41 (4), pp. 2071-2078.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Intestinal Neoplasms/*drug therapy
Neuroendocrine Tumors/*drug therapy
Pancreatic Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Female ; Fluorouracil/therapeutic use ; France/epidemiology ; Humans ; Intestinal Neoplasms/mortality ; Intestinal Neoplasms/pathology ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Neoplasm Metastasis ; Neuroendocrine Tumors/mortality ; Neuroendocrine Tumors/pathology ; Organoplatinum Compounds/therapeutic use ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Retrospective Studies ; Survival Analysis ; Treatment Outcome ; Young Adult
SCR Protocol :
Folfox protocol
Czasopismo naukowe
Tytuł :
Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
Autorzy :
van Beek DJ; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Nell S; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Verkooijen HM; Imaging Division, University Medical Center Utrecht, Utrecht, the Netherlands.
Borel Rinkes IHM; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Vriens MR; Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Pokaż więcej
Corporate Authors :
DutchMEN Study Group (DMSG)
International MEN1 Insulinoma Study Group
DutchMEN Surgery Study Group
Źródło :
Surgery [Surgery] 2021 Apr; Vol. 169 (4), pp. 963-973. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Multiple Endocrine Neoplasia Type 1/*complications
Neuroendocrine Tumors/*etiology
Neuroendocrine Tumors/*mortality
Pancreatic Neoplasms/*etiology
Pancreatic Neoplasms/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers ; Biopsy ; Child ; Diagnostic Imaging ; Disease Management ; Disease Susceptibility ; Female ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Staging ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/surgery ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/surgery ; Patient Outcome Assessment ; Prognosis ; Young Adult
Czasopismo naukowe
Tytuł :
[Analysis of clinical characteristics and prognosis of 235 pancreatic neuroendocrine tumors underwent Sunitinib treatment].
Autorzy :
Xu JM; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
Cui HT; Department of Oncology, the 940 Hospital of Joint Service of People's Liberation Army, Lanzhou 730050, China.
Jia R; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
Zhao CH; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
Zhao P; Cancer Foundation of China, Beijing 100021, China.
Pokaż więcej
Źródło :
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 Mar 23; Vol. 43 (3), pp. 324-328.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroendocrine Tumors*/drug therapy
Neuroendocrine Tumors*/surgery
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/surgery
Child, Preschool ; China/epidemiology ; Humans ; Prognosis ; Retrospective Studies ; Sunitinib/therapeutic use
Czasopismo naukowe
Tytuł :
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis.
Autorzy :
Garcia-Torralba E; Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Haematology and Medical Oncology, Hospital Morales Meseguer, Murcia, Spain.
Spada F; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
Lim KHJ; Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Jacobs T; Medical Library, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Barriuso J; Division of Cancer Sciences, University of Manchester, Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Mansoor W; Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
McNamara MG; Division of Cancer Sciences, University of Manchester, Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Hubner RA; Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Manoharan P; Department of Radiology and Nuclear Medicine, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Fazio N; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
Valle JW; Division of Cancer Sciences, University of Manchester, Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Lamarca A; Department of Medical Oncology, ENETS Centre of Excellence, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
Cancer treatment reviews [Cancer Treat Rev] 2021 Mar; Vol. 94, pp. 102168. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Bone Neoplasms/*secondary
Bone Neoplasms/*therapy
Neuroendocrine Tumors/*pathology
Neuroendocrine Tumors/*therapy
Bone Neoplasms/diagnosis ; Humans ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/secondary
Czasopismo naukowe
Tytuł :
Multimodal Imaging of 2-Cycle PRRT with Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model.
Autorzy :
Albrecht J; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Berlin, Germany.; German Cancer Research Center, Heidelberg, Germany.
Exner S; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Grötzinger C; German Cancer Consortium, Berlin, Germany.; German Cancer Research Center, Heidelberg, Germany.; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Prasad S; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Experimental Radionuclide Imaging Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Konietschke F; Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.
Beindorff N; Berlin Experimental Radionuclide Imaging Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kühl AA; iPATH.Berlin-Immunopathology for Experimental Models, Charité-Universitätsmedizin Berlin; and.
Prasad V; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany.
Brenner W; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany .; German Cancer Consortium, Berlin, Germany.; Berlin Experimental Radionuclide Imaging Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Koziolek EJ; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium, Berlin, Germany.; German Cancer Research Center, Heidelberg, Germany.
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Mar; Vol. 62 (3), pp. 393-398. Date of Electronic Publication: 2020 Aug 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Transformation, Neoplastic*
Multimodal Imaging*
Coordination Complexes/*therapeutic use
Neuroendocrine Tumors/*diagnostic imaging
Neuroendocrine Tumors/*radiotherapy
Octreotide/*analogs & derivatives
Peptides, Cyclic/*therapeutic use
Receptors, Peptide/*metabolism
Animals ; Cell Line, Tumor ; Humans ; Magnetic Resonance Imaging ; Mice ; Neuroendocrine Tumors/metabolism ; Neuroendocrine Tumors/pathology ; Octreotide/therapeutic use ; Positron-Emission Tomography ; Single Photon Emission Computed Tomography Computed Tomography
Czasopismo naukowe
Tytuł :
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet).
Autorzy :
Panzuto F; Digestive Disease Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189, Rome, Italy. .
Maccauro M; Nuclear Medicine Unit, ENETS Center of Excellence, IRRCS National Cancer Institute (INT), Milan, Italy.
Campana D; Division of Oncology, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Faggiano A; Endocrinology Unit, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Massironi S; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Pusceddu S; Oncology Unit, ENETS Center of Excellence, IRRCS National Cancer Institute (INT), Milan, Italy.
Spada F; Oncology Unit, ENETS Center of Excellence, European Cancer Institute (IEO), Milan, Italy.
Ferone D; Endocrinology Unit, IRCCS Ospedale Policlinico San Martino; Endocrinology, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.
Modica R; Department of Clinical Medicine and Surgery, University 'Federico II', Naples, Italy.
Grana CM; Nuclear Medicine Division, IRCCS European Institute of Oncology, Milan, Italy.
Ferolla P; Multidisciplinary Group for Diagnosis and Treatment of Neuroendocrine Tumors Umbria Regional Cancer Network, Perugia, Italy.
Rinzivillo M; Digestive Disease Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189, Rome, Italy.
Badalamenti G; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
Zatelli MC; Section of Endocrinology and Internal Medicine,, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Gelsomino F; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
De Carlo E; Department of Medicine, Internal Medicine III, University of Padova, Padua, Italy.
Bartolomei M; Nuclear Medicine Department, Sant'Anna Hospital, Ferrara, Italy.
Brizzi MP; Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy.
Cingarlini S; Oncology Unit, ENETS Center of Excellence, University Hospital of Verona, Verona, Italy.
Versari A; Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
Fanciulli G; NET Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari - Endocrine Unit, AOU Sassari, Sassari, Italy.
Arvat E; Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
Merola E; Department of Gastroenterology, Azienda Provinciale per i Servizi Sanitari di Trento (APSS), Trento, Italy.
Cives M; Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
Tafuto S; S.C. Sarcomi e Tumori Rari, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Napoli, Italy.
Baldari S; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, University of Messina, Messina, Italy.
Falconi M; Pancreatic Surgery, ENETS Center of Excellence, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Pokaż więcej
Źródło :
Journal of endocrinological investigation [J Endocrinol Invest] 2021 May; Vol. 44 (5), pp. 989-994. Date of Electronic Publication: 2020 Aug 16.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
COVID-19*
Pandemics*
Neuroendocrine Tumors/*therapy
Adult ; Antineoplastic Agents/therapeutic use ; Continuity of Patient Care ; Female ; Humans ; Italy/epidemiology ; Male ; Medical Oncology/statistics & numerical data ; Neuroendocrine Tumors/surgery ; Patient Care Team/statistics & numerical data ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Collision of Solid Pseudopapillary Tumor and Neuroendocrine Tumor of the Pancreas on 18F-FDG PET/CT.
Autorzy :
Yin H; From the Departments of Nuclear Medicine.
Lv J; From the Departments of Nuclear Medicine.
Chen L; Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiu Y; From the Departments of Nuclear Medicine.
Shi H; From the Departments of Nuclear Medicine.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 Apr 01; Vol. 46 (4), pp. e214-e215.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Neuroendocrine Tumors/*diagnostic imaging
Pancreatic Neoplasms/*diagnostic imaging
Adult ; Female ; Humans ; Neuroendocrine Tumors/pathology ; Neuroendocrine Tumors/surgery ; Pancreatectomy ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Pituitary neuroendocrine tumors and differentiated thyroid cancer: do metabolic and inflammatory risk factors play roles?
Autorzy :
Cortês Nascimento G; Service of Endocrinology, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil. .; Clinical Research Center, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil. .; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil. .
de Araujo Cortês Nascimento AGP; Clinical Research Center, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil.; Department of Pathology, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.
de Maria Ribeiro Veiga Parente C; Service of Endocrinology, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.
Rodrigues VP; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil.; Department of Morphology, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.
de Sousa Azulay RS; Service of Endocrinology, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Clinical Research Center, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil.
de Carvalho Rocha VC; Service of Endocrinology, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Clinical Research Center, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil.
da Silva Pereira Damianse S; Service of Endocrinology, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Clinical Research Center, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil.
Magalhães M; Clinical Research Center, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil.
Dos Santos Faria M; Service of Endocrinology, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Clinical Research Center, Presidente Dutra University Hospital, Federal University of Maranhão (UFMA), São Luís, MA, Brazil.; Research Group in Clinical and Molecular Endocrinology and Metabology (ENDOCLIM), São Luís, MA, Brazil.
Gomes MB; Diabetes Unit-Department of Internal Medicine, State University of Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
Pokaż więcej
Źródło :
Journal of endocrinological investigation [J Endocrinol Invest] 2021 Apr; Vol. 44 (4), pp. 735-744. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiometabolic Risk Factors*
Adenocarcinoma/*etiology
Inflammation/*complications
Neuroendocrine Tumors/*complications
Pituitary Neoplasms/*complications
Thyroid Neoplasms/*etiology
Acromegaly/complications ; Acromegaly/epidemiology ; Acromegaly/metabolism ; Adenocarcinoma/epidemiology ; Adenocarcinoma/metabolism ; Adult ; Aged ; Aged, 80 and over ; Blood Glucose/metabolism ; Brazil/epidemiology ; Case-Control Studies ; Cross-Sectional Studies ; Female ; Humans ; Incidence ; Inflammation/epidemiology ; Inflammation/metabolism ; Insulin/metabolism ; Insulin Resistance/physiology ; Male ; Middle Aged ; Neuroendocrine Tumors/epidemiology ; Neuroendocrine Tumors/metabolism ; Pituitary Neoplasms/epidemiology ; Pituitary Neoplasms/metabolism ; Risk Factors ; Thyroid Neoplasms/epidemiology ; Thyroid Neoplasms/metabolism ; Young Adult
Czasopismo naukowe
Tytuł :
Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study.
Autorzy :
Li X; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China.
Shao L; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China.
Lu X; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China.
Yang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Ai S; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China.
Sun F; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China.
Wang M; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China. .
Guan W; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China. .
Liu S; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan RD, Nanjing, 210008, China. .
Pokaż więcej
Źródło :
BMC surgery [BMC Surg] 2021 Mar 31; Vol. 21 (1), pp. 174. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphatic Metastasis*
Neuroendocrine Tumors*/pathology
Neuroendocrine Tumors*/surgery
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Aged ; Humans ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Autorzy :
Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Takeda DY; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Hwang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Arafeh R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Arnoff T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Agarwal S; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
O'Connor E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Alaiwi SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Corona RI; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Fonseca MAS; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Giambartolomei C; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Istituto Italiano di Tecnologia, Genova, Italy.
Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Lim K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
He M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Sheahan A; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nassar A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Brown L; Department of Urology, University of Washington, Seattle, WA, USA.
Nguyen HM; Department of Urology, University of Washington, Seattle, WA, USA.
Coleman IM; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Kaipainen A; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
De Sarkar N; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Morrissey C; Department of Urology, University of Washington, Seattle, WA, USA.
Korthauer K; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Ellis L; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pasaniuc B; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Lawrenson K; Department of Obstetrics and Gynecology and the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Center for Bioinformatics and Functional Genomics, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Kelly K; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Zoubeidi A; Vancouver Prostate Centre, Vancouver, BC, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.
Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Corey E; Department of Urology, University of Washington, Seattle, WA, USA.
Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. .; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. .; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 30; Vol. 12 (1), pp. 1979. Date of Electronic Publication: 2021 Mar 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Adenocarcinoma/*genetics
Hepatocyte Nuclear Factor 3-alpha/*genetics
Neuroendocrine Tumors/*genetics
Prostatic Neoplasms/*genetics
Adenocarcinoma/metabolism ; Adenocarcinoma/therapy ; Animals ; Cell Line, Tumor ; Disease Progression ; Epigenomics/methods ; Hepatocyte Nuclear Factor 3-alpha/metabolism ; Humans ; Male ; Mutation ; Neuroendocrine Tumors/metabolism ; Neuroendocrine Tumors/therapy ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/therapy ; RNA Interference ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism
Czasopismo naukowe
Tytuł :
CD47 expression and CD163 macrophages correlated with prognosis of pancreatic neuroendocrine tumor.
Autorzy :
Imam R; Department of Pathology, New York University Grossman School of Medicine, 560 1st Ave, Tisch 4-15I, New York, NY, 10016, USA.
Chang Q; Department of Pathology, New York University Grossman School of Medicine, 560 1st Ave, Tisch 4-15I, New York, NY, 10016, USA.
Black M; Department of Pathology, New York University Grossman School of Medicine, 560 1st Ave, Tisch 4-15I, New York, NY, 10016, USA.
Yu C; Department of Pathology, New York University Grossman School of Medicine, 560 1st Ave, Tisch 4-15I, New York, NY, 10016, USA.
Cao W; Department of Pathology, New York University Grossman School of Medicine, 560 1st Ave, Tisch 4-15I, New York, NY, 10016, USA. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Mar 25; Vol. 21 (1), pp. 320. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Biomarkers, Tumor/*metabolism
CD47 Antigen/*metabolism
Neoplasm Recurrence, Local/*epidemiology
Neuroendocrine Tumors/*surgery
Pancreatic Neoplasms/*surgery
Tumor-Associated Macrophages/*immunology
Aged ; Antigens, CD/metabolism ; Antigens, Differentiation, Myelomonocytic/metabolism ; Biomarkers, Tumor/analysis ; CD47 Antigen/analysis ; Cell Count ; Female ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Lymphatic Metastasis/immunology ; Lymphatic Metastasis/pathology ; Male ; Middle Aged ; Neoplasm Invasiveness/immunology ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/pathology ; Neuroendocrine Tumors/immunology ; Neuroendocrine Tumors/mortality ; Neuroendocrine Tumors/pathology ; Pancreas/cytology ; Pancreas/pathology ; Pancreatectomy ; Pancreatic Neoplasms/immunology ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Prognosis ; Receptors, Cell Surface/metabolism ; Risk Assessment/methods ; Survival Analysis ; Tumor-Associated Macrophages/metabolism
Czasopismo naukowe
Tytuł :
The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Autorzy :
Burak GI; Cukurova University Faculty of Medicine Nuclear Medicine Department of Balcali Hospital and Clinics, Adana, Turkey.
Ozge S; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey.
Cem M; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center), Adana, Turkey.
Gulgun B; Cukurova University Faculty of Medicine Nuclear Medicine Department of Balcali Hospital and Clinics, Adana, Turkey.
Zeynep DY; Cukurova University Faculty of Medicine Nuclear Medicine Department of Balcali Hospital and Clinics, Adana, Turkey.
Atil B; Cukurova University AGENTEM & Cukurova University Faculty of Medicine Medical Genetics Department of Balcali Hospital and Clinics, Adana, Turkey. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Mar 06; Vol. 21 (1), pp. 234. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article
MeSH Terms :
Genetic Testing*
Biomarkers, Tumor/*genetics
Cell-Free Nucleic Acids/*genetics
Neuroendocrine Tumors/*diagnosis
Adolescent ; Adult ; Aged ; Biomarkers, Tumor/blood ; Cell-Free Nucleic Acids/blood ; Female ; Genetic Predisposition to Disease ; High-Throughput Nucleotide Sequencing ; Humans ; Liquid Biopsy ; Male ; Middle Aged ; Mutation ; Neuroendocrine Tumors/blood ; Neuroendocrine Tumors/genetics ; Neuroendocrine Tumors/therapy ; Precision Medicine/methods ; Young Adult
Czasopismo naukowe
Tytuł :
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of Lu-DOTA-EB-TATE.
Autorzy :
Liu Q; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Zang J; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Sui H; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Ren J; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Guo H; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Wang H; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Wang R; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Jacobson O; Departments of Diagnostic Radiology, Chemical and Biomolecular Engineering, Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, Singapore.
Zhang J; Theranostics Center for Molecular Radiotherapy and Precision Oncology, Zentralklinik Bad Berka, Bad Berka, Germany; and.
Cheng Y; Division of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zhu Z; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Chen X; Departments of Diagnostic Radiology, Chemical and Biomolecular Engineering, Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, Singapore .
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Mar; Vol. 62 (3), pp. 386-392. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neuroendocrine Tumors/*pathology
Neuroendocrine Tumors/*radiotherapy
Receptors, Peptide/*metabolism
Somatostatin/*analogs & derivatives
Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Neuroendocrine Tumors/metabolism ; Safety ; Somatostatin/therapeutic use
Czasopismo naukowe
Tytuł :
Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis.
Autorzy :
Fahmy JN; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA. Electronic address: .
Varsanik MA; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
Hubbs D; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA.
Eguia E; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA.
Abood G; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA.
Knab LM; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA.
Pokaż więcej
Źródło :
American journal of surgery [Am J Surg] 2021 Mar; Vol. 221 (3), pp. 529-533. Date of Electronic Publication: 2020 Dec 24.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroendocrine Tumors/*mortality
Neuroendocrine Tumors/*surgery
Pancreatic Neoplasms/*mortality
Pancreatic Neoplasms/*surgery
Postoperative Complications/*epidemiology
Adult ; Aged ; Female ; Humans ; Length of Stay ; Male ; Middle Aged ; Minimally Invasive Surgical Procedures ; Neuroendocrine Tumors/pathology ; Pancreatectomy ; Pancreatic Neoplasms/pathology ; Retrospective Studies ; Splenectomy ; Survival Analysis ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Adrenocorticotropic hormone-secreting pancreatic neuroendocrine tumor manifested with intermittent hypertension: a case report].
Autorzy :
He XY; Branch of National Clinical Research Center for Metabolic Diseases, Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Yu XF; Branch of National Clinical Research Center for Metabolic Diseases, Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Xie JH; Branch of National Clinical Research Center for Metabolic Diseases, Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Pokaż więcej
Źródło :
Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2021 May 01; Vol. 60 (5), pp. 472-475.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
ACTH Syndrome, Ectopic*
Hypertension*
Neuroendocrine Tumors*
Pancreatic Neoplasms*/complications
Adrenocorticotropic Hormone ; Humans
Czasopismo naukowe
Tytuł :
Primary Neuroendocrine Neoplasia of the Liver.
Autorzy :
Kaemmerer D; From the Department of General and Visceral Surgery, Zentralklinik Bad Berka.
Kunze A; Institute of Pathology Thuringia.
Robiller FC; Department of Nuclear Medicine, Zentralklinik Bad Berka, Bad Berka.
Hommann M; From the Department of General and Visceral Surgery, Zentralklinik Bad Berka.
Anlauf M; ÜGP MVZ Institute for Pathology, Cytology and Molecular Pathology, Limburg, Germany; ENETS Center of Excellence.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 May 01; Vol. 46 (5), pp. 409-410.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Liver Neoplasms/*diagnostic imaging
Neuroendocrine Tumors/*diagnostic imaging
Aged ; Female ; Humans ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neuroendocrine Tumors/pathology ; Octreotide/analogs & derivatives ; Organometallic Compounds
Czasopismo naukowe
Tytuł :
68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor.
Autorzy :
Kömek H; From the Department of Nuclear Medicine, Gazi Yaşargil Training and Research Hospital, University of Health Sciences, Diyarbakir, Turkey.
Gündoğan C
Can C
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 May 01; Vol. 46 (5), pp. e290-e292.
Typ publikacji :
Case Reports; Comparative Study; Journal Article
MeSH Terms :
Organometallic Compounds*
Positron Emission Tomography Computed Tomography*
Quinolines*
Neuroendocrine Tumors/*diagnostic imaging
Biopsy ; Humans ; Male ; Middle Aged ; Neuroendocrine Tumors/pathology
Czasopismo naukowe
Tytuł :
Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms.
Autorzy :
Hasegawa S; Oncology Division, Yokohama City University Hospital, Japan.; Gastroenterology and Hepatology Division, Yokohama City University Hospital, Japan.
Kobayashi N; Oncology Division, Yokohama City University Hospital, Japan.
Okubo N; Oncology Division, Yokohama City University Hospital, Japan.
Tokuhisa M; Oncology Division, Yokohama City University Hospital, Japan.
Goto A; Oncology Division, Yokohama City University Hospital, Japan.
Kurita Y; Gastroenterology and Hepatology Division, Yokohama City University Hospital, Japan.
Sato T; Gastroenterology and Hepatology Division, Yokohama City University Hospital, Japan.
Hosono K; Gastroenterology and Hepatology Division, Yokohama City University Hospital, Japan.
Endo I; Gastroenterological Surgery Division, Yokohama City University Hospital, Japan.
Nakajima A; Gastroenterology and Hepatology Division, Yokohama City University Hospital, Japan.
Ichikawa Y; Oncology Division, Yokohama City University Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Apr 01; Vol. 60 (7), pp. 977-983. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroendocrine Tumors*
Stomach Neoplasms*
B7-H1 Antigen ; Biomarkers, Tumor ; Humans ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study.
Autorzy :
Crinó SF; Gastroenterology and Digestive Endoscopy Unit, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Brandolese A; Gastroenterology and Digestive Endoscopy Unit, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Vieceli F; Gastroenterology and Digestive Endoscopy Unit, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Paiella S; Unit of General and Pancreatic Surgery, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Conti Bellocchi MC; Gastroenterology and Digestive Endoscopy Unit, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Manfrin E; Department of Diagnostics and Public Health, Integrated University-Hospital of Verona, Italy.
Bernardoni L; Gastroenterology and Digestive Endoscopy Unit, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Sina S; Department of Diagnostics and Public Health, Integrated University-Hospital of Verona, Italy.
D'Onofrio M; Department of Radiology, Integrated University-Hospital of Verona, Italy.
Marchegiani G; Unit of General and Pancreatic Surgery, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Larghi A; Digestive Endoscopy Unit, University-Hospital Agostino Gemelli, Roma, Italy.
Frulloni L; Gastroenterology and Digestive Endoscopy Unit, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Landoni L; Unit of General and Pancreatic Surgery, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Gabbrielli A; Gastroenterology and Digestive Endoscopy Unit, The Pancreas-Institute, Integrated University-Hospital of Verona, Italy.
Pokaż więcej
Transliterated Title :
Endoskopische Ultraschallmerkmale assoziiert mit Malignität und Aggressivität bei nicht hypovaskulären soliden Pankreasläsionen: Ergebnisse einer prospektiven Beobachtungsstudie.
Źródło :
Ultraschall in der Medizin (Stuttgart, Germany : 1980) [Ultraschall Med] 2021 Apr; Vol. 42 (2), pp. 167-177. Date of Electronic Publication: 2019 Oct 09.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Neuroendocrine Tumors*/diagnostic imaging
Pancreatic Neoplasms*/diagnostic imaging
Endoscopic Ultrasound-Guided Fine Needle Aspiration ; Endosonography ; Humans ; Pancreas/diagnostic imaging ; Prospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies